Stay updated on Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.

Latest updates to the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.3.4 was added to the history and an older entry v3.3.3 was removed. This update affects only the history log metadata and does not alter study data or page functionality.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedMinor UI updates: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2', with no impact on study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check45 days agoChange DetectedNew entries for Contacts/Locations and Study Status were added in the record history (dated 2025-12-04 and 2025-12-03). A deletion was recorded on 2025-10-09.SummaryDifference0.4%

- Check60 days agoChange DetectedRevision history shows a new entry 'Revision: v3.3.2' added and 'Revision: v3.2.0' removed; this is a minor metadata update to the page history and does not affect core study information or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoved the site-wide government funding/operating status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check81 days agoChange DetectedThe new screenshot shows a redesigned header and layout on the Record History page, while the version history list and study details remain the same.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.